We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
An inability to maintain abstinence is a key indicator of tobaccodependence.
2
We review the currently available pharmacologic approaches to the treatment of tobaccodependence.
3
Rationale: Anhedonia-diminished capacity to experience pleasure-is associated with tobaccodependence and smoking cessation failure.
4
Several effective pharmacotherapies are available to treat tobaccodependence.
5
He combines clinical research and clinical care in lifestyle treatments for obesity, diabetes, and tobaccodependence.
6
The age-related pattern for concurrent alcohol and tobaccodependence was similar to that found for tobaccodependence.
7
Unfortunately, little evidence exists regarding the ability of the major tobaccodependence measures to predict smoking cessation outcome.
8
Advice by a healthcare provider to quit is associated with increased use of effective therapies for tobaccodependence.
9
Nicotine is the psychoactive substance responsible for tobaccodependence; smokers adjust their cigarette consumption to maintain brain nicotine levels.
10
Although tobacco smoke contains many substances, researchers and policymakers agree that nicotine is a major cause of tobaccodependence.
11
CYP2A6 inhibition may have potential as an exposure reduction or cessation strategy in tobaccodependence.
12
In these families, ADHD is highly comorbid with conduct and oppositional defiant disorders, as well as with alcohol and tobaccodependence.
13
These findings point to CB1-receptor neutral antagonists as a new class of medications for treatment of both tobaccodependence and cannabis dependence.
14
Raymond Niaura is a psychologist and an expert on tobaccodependence and treatment, as well as substance use and addiction to alcohol.
15
Identification of differences between smokers and non-smokers on basic characteristics of neurocognitive functioning may help to elucidate the mechanisms of tobaccodependence.
16
Another author, Dr Karl Fagerström, has served as "a consultant for most companies with an interest in tobaccodependence treatments".